Additionally, ENHO was positively co-expressed with MHC class II presentation genes (including HLA-DMA, HLA-DOA, HLA-DPA1, HLA-DPB1, and HLA-DRB1), supporting its role in promoting anti-tumor immunity. The gene discussed is HLA-DPA1; the disease is neoplasm.